PRESS

GADOR R&D: A WIDE SCOPE OF ENDEAVORS – FROM TECHNOLOGICAL INNOVATION TO SOCIAL INSERTION.

- 20 April, 2015

Most pharmaceutical innovations come from a privileged group of countries, to which Latin American nations seldom belong. Yet Gador SA has led a number of scientific ventures and received several scientific awards. The company has also been granted various international patents for its inventions. Such endeavors, which are uncommon in this region, stem from the […]

Ver artículo completo

PepTcell and Gador Announce Collaboration to Develop Novel Vaccine for “Neglected” Chagas disease

- 10 December, 2007

High Wycombe, UK and Buenos Aires, Argentina – 14th December 2007 PepTcell Ltd. and Gador S.A. today announced an R&D collaboration to develop a novel T-cell vaccine for Chagas disease, a neglected tropical disease with no adequate treatment or vaccination. PepTcell will develop the T-cell vaccine, using its proprietary technology and expertise to identify parasitic […]

Ver artículo completo